Advertisement
Advertisement
U.S. Markets open in 2 hrs 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Bluejay Diagnostics, Inc. (BJDX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.4724+0.0325 (+7.39%)
At close: 03:59PM EST
0.4500 -0.02 (-4.74%)
Pre-Market: 05:32AM EST
Advertisement

Bluejay Diagnostics, Inc.

360 Massachusetts Avenue
Suite 203
Acton, MA 01720
United States
844 327 7078
https://www.bluejaydx.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Indranil DeyPres, CEO & Director181.61kN/A1964
Dr. Jason CookChief Technology Officer308.3kN/A1982
Mr. Kenneth R. Fisher CPAChief Financial OfficerN/AN/A1980
Mr. Edwin RuleVP of Regulatory, Quality & ComplianceN/AN/AN/A
Mr. Kevin VanceChief Commercial OfficerN/AN/A1957
Mark W. FeinbergChief Medical AdvisorN/AN/AN/A
Dr. Mark W. Feinberg M.D.Chief Medical AdvisorN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Corporate Governance

Bluejay Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement